Literature DB >> 34541878

Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.

Anello Marcello Poma1, Alessio Basolo2, Diana Bonuccelli3, Agnese Proietti1, Elisabetta Macerola1, Clara Ugolini1, Liborio Torregrossa1, Greta Alì1, Riccardo Giannini1, Paola Vignali1, Ferruccio Santini2, Antonio Toniolo4, Fulvio Basolo1.   

Abstract

Background: Thyroid dysfunctions have been reported after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. However, the biological mechanisms behind these conditions remain unexplored. Herein, we report on changes of the immune transcriptome in autoptic thyroid tissues of people who have died from coronavirus disease 2019 (COVID-19).
Methods: Twenty-five autoptic thyroid specimens of subjects dying from COVID-19 were investigated. Eleven autoptic thyroid specimens of subjects dying from causes other than infectious conditions served as controls. RNA transcripts of 770 immune-related genes together with RNA genomes of multiple coronavirus types were measured by the nCounter system. Reverse transcription-polymerase chain reaction for two SARS-CoV-2 genes was used to assess virus positivity. Results were validated by immunohistochemistry.
Results: The SARS-CoV-2 genome and antigens were detected in 9 of 25 (36%) thyroid specimens from the COVID-19 cohort. Virus-negative thyroid tissues from COVID-19 subject did not show changes of gene transcription nor significant numbers of infiltrating immune cells. Conversely, SARS-CoV-2-positive thyroid specimens showed marked upregulation of immune genes, especially those proper of the type I and type II interferon (IFN) pathways. In infected tissues, infiltrates of innate immune cells (macrophages and polymorphonuclear neutrophils) were prevalent. Conclusions: The thyroid gland can be directly infected by the SARS-CoV-2. Infection strongly activates IFN pathways. The direct viral insult combined with an intense immune response may trigger or worsen thyroid conditions in predisposed individuals.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; autopsy; interferons; thyroid

Mesh:

Substances:

Year:  2021        PMID: 34541878     DOI: 10.1089/thy.2021.0345

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  8 in total

1.  ACE2 and TMPRSS2 Immunolocalization and COVID-19-Related Thyroid Disorder.

Authors:  Gi-Cheol Park; Hyoun-Wook Lee; Ji-Min Kim; Ji-Min Han; Hye-In Kim; Sung-Chan Shin; Yong-Il Cheon; Eui-Suk Sung; Minhyung Lee; Jin-Choon Lee; Dong-Min Shin; Byung-Joo Lee
Journal:  Biology (Basel)       Date:  2022-04-30

Review 2.  The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine.

Authors:  Mihaela Popescu; Adina Ghemigian; Corina Maria Vasile; Andrei Costache; Mara Carsote; Alice Elena Ghenea
Journal:  Diagnostics (Basel)       Date:  2022-04-12

3.  SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?

Authors:  S Ippolito; D Gallo; S Uccella; M L Tanda; A Baj; F Novazzi; A Genoni; M Annoni; N Mancini; N Clementi; G Finzi; E Piantanida; P Premoli; A Lai; D Dalla Gasperina; F Maggi
Journal:  J Endocrinol Invest       Date:  2022-01-05       Impact factor: 4.256

4.  A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus Infection and Thyroid Disease with Follow-Up Thyroid Function and Autoantibody Testing.

Authors:  Dumitru Cristinel Badiu; Gabriel Cristian Popescu; Anca Zgura; Adriana Mercan Stanciu; Mihai Daniel Dodot; Claudia Mehedintu; Letitia Toma; Simu Razvan; Xenia Bacinschi; Bogdan Haineala
Journal:  Med Sci Monit       Date:  2021-12-31

5.  Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series.

Authors:  Sofia Macedo; Ana Pestana; Liliana Santos; Celestino Neves; Susana Guimarães; Amaro Duarte-Neto; Marisa Dolhnikoff; Paulo Saldiva; Georgina Alves; Rute Oliveira; Didier Cabanes; Fátima Carneiro; Manuel Sobrinho-Simões; Paula Soares
Journal:  Eur Thyroid J       Date:  2022-07-19

6.  High Prevalence of Common Human Viruses in Thyroid Tissue.

Authors:  Therese Weider; Angelo Genoni; Francesco Broccolo; Trond H Paulsen; Knut Dahl-Jørgensen; Antonio Toniolo; Sara Salehi Hammerstad
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

7.  Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients.

Authors:  D T W Lui; C H Lee; W S Chow; A C H Lee; A R Tam; C Y Y Cheung; C H Y Fong; S T M Kwok; C Y Law; K K W To; C W Lam; K C B Tan; Y C Woo; I F N Hung; K S L Lam
Journal:  J Endocrinol Invest       Date:  2022-07-13       Impact factor: 5.467

8.  Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis.

Authors:  Daniele Cappellani; Liborio Torregrossa; Piermarco Papini; Anello Marcello Poma; Enrico Ambrosini; Luigi De Napoli; Gabriele Materazzi; Fulvio Basolo; Fausto Bogazzi
Journal:  Endocrine       Date:  2022-03-12       Impact factor: 3.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.